doi: 10.1007/s12602-017-9322-6 74 GrondinJAKwonYHFarPMHaqS
The approval of Mounjaro is an exciting step forward for people living with type 2 diabetes given the results seen in these clinical trials. Patrick Archdeacon, MD, associate director of the Division of Diabetes, Lipid Disorders and Obesity within the FDAs Center for Drug Evaluation and Research, also commented on the approval in an agency statement
/ (/) // 49 198720025,000 (/) 1()2()41()(HbA1c)6.5%()126mg/dL()2200 mg/dL()()200 mg/dL (/) 587886kg169BMI30metformin 2#glimepiride 2#8.7%(23)GLP-17.1%83 dulaglutideGLP-1(glucagon-like peptide 1)30L (glucagon-like peptide-1 agonists, GLP-1 agonists)(/) GLP-1GLP-11.5%2-2.5
Recommendation: Take 1 mL (approximately 2 pumps) by mouth daily, or as directed by a healthcare professional
Adults usually getvitamin B12 injections in doses of 1000 mcg, based on the deficiency level
Eli Lilly has not submitted a New Drug Application (NDA) to the FDA